Clinical Features and Outcome in North American Adults With Moyamoya Phenomenon
- 1 June 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 37 (6) , 1490-1496
Abstract
Background and Purpose— To describe baseline clinical features and outcomes of adults with moyamoya phenomenon treated at a single North American institution. Methods— We identified 34 adults with moyamoya phenomenon by review of angiographic records. Clinical presentation and baseline stroke risk factors were obtained by chart review. Follow-up was obtained prospectively. A 5-year Kaplan-Meier stroke risk was calculated. Results— The median age was 42 (range 20 to 79) years. Twenty-five were women. The initial symptom was ischemia, hemorrhage, or asymptomatic in 24, 7, and 3 patients, respectively. Twenty-two had bilateral involvement and 12 had unilateral moyamoya vessels. Baseline stroke risk factors were similar between groups. The median follow-up in 31 living patients was 5.1 (range 0.2 to 19.6) years. Fourteen patients were treated with surgical revascularization (20 total hemispheres). In medically treated symptomatic hemispheres, the 5-year risk of recurrent ipsilateral stroke was 65% after the initial symptom and 27% after angiographic diagnosis. Patients with bilateral involvement presenting with ischemic symptoms were at the highest risk of subsequent stroke (n=17, 5-year risk of stroke with medical treatment after first symptom of 82%). In surgically treated hemispheres, the 5-year risk of perioperative or subsequent ipsilateral stroke or death was 17%. This was significantly different compared with medical treatment after first symptom ( P =0.02) but not after angiographic diagnosis. Conclusion— Moyamoya phenomenon in North American adults is associated with a high risk of recurrent stroke, particularly those with bilateral involvement and ischemic symptoms. These data suggest a potential benefit with surgery if diagnosis could be made earlier.Keywords
This publication has 12 references indexed in Scilit:
- Incidence and Clinical Features of Disease Progression in Adult Moyamoya DiseaseStroke, 2005
- Moyamoya disease in Washington State and CaliforniaNeurology, 2005
- Hemodynamic Reserve and High-Intensity Transient Signals in Moyamoya DiseaseCerebrovascular Diseases, 2005
- Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosisThe Lancet, 2003
- Cerebrovascular Reactivity to Acetazolamide and Outcome in Patients With Symptomatic Internal Carotid or Middle Cerebral Artery OcclusionStroke, 2002
- MoyamoyaArchives of Neurology, 2001
- Cerebral hemodynamic impairmentNeurology, 1999
- Importance of Hemodynamic Factors in the Prognosis of Symptomatic Carotid OcclusionJAMA, 1998
- Complex regional pain syndrome (reflex sympathetic dystrophy and causalgia): management with the calcium channel blocker nifedipine and/or the α-sympathetic blocker phenoxybenzamine in 59 patientsClinical Neurology and Neurosurgery, 1997
- Cerebrovascular "Moyamoya" DiseaseArchives of Neurology, 1969